LATEST NEWS

A phase 1 trial of NBTXR3 nanoparticles activated by IMRT in the treatment of advanced-stage head and neck carcinoma

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.